CDC50A and cancer: In cancer cells, sporadic mutations in TMEM30A have been linked to lymphomas such as diffuse large B-cell lymphoma (DLBCL) [56] and follicular lymphoma [57], although it still remains to be determined if the oncogenic potentials are directly related to PS externalization.